Vytorin in Chronic Kidney Disease Gets FDA Committee Nod Internal Medicine News Digital Network Vytorin should be approved for preventing major vascular events in patients who have chronic kidney disease but are not on dialysis, according to a unanimous vote by an Food and Drug Administration advisory panel. However the panel also voted 10-6 that ... FDA committee recommends new drug applications for ezetimibe, simvastatin |
